Normal View Dyslexic View

Ondansetron for low anterior resection syndrome (LARS). A double-blind, placebo-controlled, cross-over, randomized study.

27 June 2024
Randomized clinical trials Colorectal
Popeskou SG, Roesel R, Faes S, Vanoni A, Galafassi J, di Tor Vajana AF et al.

Ann Surg 2024; 279: 196-202.

Thirty-four patients with symptomatic low anterior resection syndrome (LARS) were included. Those randomized to Ondansetron first had improved LARS scores, whereas those who had Ondansetron second, tended to have deteriorating scores. Treatment was safe.

Comment: Good treatment for an unpleasant condition.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
Info
Copied!